Experimental and Molecular Medicine (Jul 2024)

FGFR3 drives Aβ-induced tau uptake

  • Dong Kyu Kim,
  • Kyujin Suh,
  • Junho Park,
  • Sang-Eun Lee,
  • Jihui Han,
  • Sunghoe Chang,
  • Youngsoo Kim,
  • Inhee Mook-Jung

DOI
https://doi.org/10.1038/s12276-024-01274-3
Journal volume & issue
Vol. 56, no. 7
pp. 1631 – 1642

Abstract

Read online

Abstract The amyloid cascade hypothesis suggests that amyloid beta (Aβ) contributes to initiating subsequent tau pathology in Alzheimer’s disease (AD). However, the underlying mechanisms through which Aβ contributes to tau uptake and propagation remain poorly understood. Here, we show that preexisting amyloid pathology accelerates the uptake of extracellular tau into neurons. Using quantitative proteomic analysis of endocytic vesicles, we reveal that Aβ induces the internalization of fibroblast growth factor receptor 3 (FGFR3). Extracellular tau binds to the extracellular domain of FGFR3 and is internalized by the FGFR3 ligand, fibroblast growth factor 2 (FGF2). Aβ accelerates FGF2 secretion from neurons, thereby inducing the internalization of tau-attached FGFR3. Knockdown of FGFR3 in the hippocampus reduces tau aggregation by decreasing tau uptake and improving memory function in AD model mice. These data suggest FGFR3 in neurons as a novel tau receptor and a key mediator of Aβ-induced tau uptake in AD.